Stocks
Cantel Medical Financial Statements (CMD) |
||||||||||
| Cantel Medicalsmart-lab.ru | % | 2016 | 2017 | 2018 | 2019 | 2020 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 29.09.2016 | 28.09.2017 | 27.09.2018 | 25.09.2019 | 25.09.2020 | 28.05.2021 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 664.8 | 770.2 | 871.9 | 918.2 | 1 016 | 1 216 | |||
| Operating Income, bln rub | 97.3 | 110.5 | 122.8 | 84.8 | 48.3 | 154.3 | ||||
| EBITDA, bln rub | ? | 122.4 | 144.0 | 157.6 | 127.2 | 122.7 | 236.4 | |||
| Net profit, bln rub | ? | 60.0 | 71.4 | 91.0 | 55.0 | 13.7 | 66.4 | |||
| OCF, bln rub | ? | 80.3 | 108.2 | 125.9 | 66.9 | 136.9 | 166.1 | |||
| CAPEX, bln rub | ? | 18.9 | 27.1 | 37.7 | 95.4 | 33.8 | 42.7 | |||
| FCF, bln rub | ? | 61.4 | 81.1 | 88.2 | -28.5 | 103.1 | 123.4 | |||
| Dividend payout, bln rub | 5.01 | 5.84 | 7.09 | 8.35 | 4.47 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 8.35% | 8.18% | 7.79% | 15.2% | 32.6% | 0 | ||||
| OPEX, bln rub | 211.9 | 256.8 | 292.3 | 343.9 | 387.7 | 435.3 | ||||
| Cost of production, bln rub | 355.6 | 403.0 | 458.0 | 490.7 | 580.1 | 626.4 | ||||
| R&D, bln rub | 15.4 | 18.4 | 24.6 | 31.3 | 32.4 | 31.0 | ||||
| Interest expenses, bln rub | 3.41 | 4.30 | 5.29 | 9.51 | 41.4 | 60.7 | ||||
| Assets, bln rub | 694.5 | 786.4 | 963.7 | 1 070 | 2 072 | 2 031 | ||||
| Net Assets, bln rub | ? | 454.4 | 523.9 | 608.9 | 661.5 | 729.6 | 817.2 | |||
| Debt, bln rub | 116.0 | 126.0 | 197.3 | 230.9 | 1 059 | 891.6 | ||||
| Cash, bln rub | 28.4 | 36.6 | 94.1 | 44.5 | 277.9 | 218.5 | ||||
| Net debt, bln rub | 87.6 | 89.4 | 103.2 | 186.3 | 781.2 | 673.0 | ||||
| Ordinary share price, rub | 66.9 | 74.2 | 92.7 | 92.3 | 47.3 | 81.4 | ||||
| Number of ordinary shares, mln | 41.6 | 41.7 | 41.7 | 41.8 | 42.8 | 42.2 | ||||
| Market cap, bln rub | 2 787 | 3 096 | 3 867 | 3 855 | 2 024 | 3 437 | ||||
| EV, bln rub | ? | 2 875 | 3 186 | 3 970 | 4 041 | 2 805 | 4 110 | |||
| Book value, bln rub | 62 | 88 | 103 | 142 | -411 | -304 | ||||
| EPS, rub | ? | 1.44 | 1.71 | 2.18 | 1.32 | 0.32 | 1.57 | |||
| FCF/share, rub | 1.47 | 1.94 | 2.12 | -0.68 | 2.41 | 2.92 | ||||
| BV/share, rub | 1.50 | 2.11 | 2.48 | 3.40 | -9.59 | -7.19 | ||||
| EBITDA margin, % | ? | 18.4% | 18.7% | 18.1% | 13.9% | 12.1% | 19.4% | |||
| Net margin, % | ? | 9.02% | 9.27% | 10.4% | 5.99% | 1.35% | 5.46% | |||
| FCF yield, % | ? | 2.20% | 2.62% | 2.28% | -0.74% | 5.09% | 3.59% | |||
| ROE, % | ? | 13.2% | 13.6% | 15.0% | 8.32% | 1.88% | 8.12% | |||
| ROA, % | ? | 8.63% | 9.08% | 9.45% | 5.14% | 0.66% | 3.27% | |||
| P/E | ? | 46.5 | 43.4 | 42.5 | 70.0 | 147.7 | 51.8 | |||
| P/FCF | 45.4 | 38.2 | 43.8 | -135.2 | 19.6 | 27.9 | ||||
| P/S | ? | 4.19 | 4.02 | 4.43 | 4.20 | 1.99 | 2.83 | |||
| P/BV | ? | 44.7 | 35.2 | 37.4 | 27.2 | -4.93 | -11.3 | |||
| EV/EBITDA | ? | 23.5 | 22.1 | 25.2 | 31.8 | 22.9 | 17.4 | |||
| Debt/EBITDA | 0.72 | 0.62 | 0.65 | 1.46 | 6.37 | 2.85 | ||||
| R&D/CAPEX, % | 81.6% | 67.9% | 65.4% | 32.8% | 95.8% | 72.6% | ||||
| CAPEX/Revenue, % | 2.84% | 3.51% | 4.32% | 10.4% | 3.33% | 3.51% | ||||
| Cantel Medical shareholders | ||||||||||
